Position of the american dietetic association: Nutrition intervention and human immunodeficiency virus infection

Journal of the American Dietetic Association

Volumn 110, Issue 7, 2010, Pages 1105-1119

  Fields Gardner, Cade ^a   Campa, Adriana ^b   Denny, Sharon ^c   Eliasi, Jennifer R ^d   Fletcher Pope, Lucille ^e   Hager, Mary H ^f   Jones, J ^g   Mueller, Charles ^h   Myers, Esther ^c   Rothpletz Puglia, Pamela ⁱ   Ronco, Lisa ^j  

^a TCE Consulting Group Inc   (United States)

^b FLORIDA INTERNATIONAL UNIVERSITY   (United States)

^c AMERICAN DENTAL ASSOCIATION   (United States)

^d EMD Serono Forest Hills   (United States)

^e ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^f ADA Government Relations   (United States)

^g Near North Health Service Corporation   (United States)

^h WEILL CORNELL MEDICAL COLLEGE   (United States)

ⁱ Village Care of New York   (United States)

^j The State University of New Jersey   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; DIET THERAPY; DIETETICS; HEALTH CARE ORGANIZATION; HOSPITALIZATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; NUTRITIONAL ASSESSMENT; NUTRITIONAL DISORDER; NUTRITIONAL STATUS; PRACTICE GUIDELINE; STANDARD; UNITED STATES;

DIETETICS; HIV INFECTIONS; HUMANS; NUTRITION ASSESSMENT; NUTRITION DISORDERS; NUTRITION THERAPY; NUTRITIONAL STATUS; SEVERITY OF ILLNESS INDEX; SOCIETIES; UNITED STATES;

EID: 77954986432     PISSN: 00028223     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jada.2010.05.020     Document Type: Article

References (153)

1. Mykhalovskiy E, Brown G, Kort R. XVII International AIDS Conference: From evidence to action-Social, behavioural and economic science and policy and political science. J Int AIDS Soc. 2009;12(suppl 1):S5.
2. Report on the Global AIDS Epidemic. Executive Summary. Joint United National Programme on HIV/AIDS Web site. http:// data.unaids.org/pub/GlobalReport/2008/ JC1511_GR08_ExecutiveSummary_en.pdf. Posted July 2008. Accessed July 23, 2009.
3. HIV/AIDS data through December 2006. Centers for Disease Control and Prevention Web site. http://www.cdc.gov/hiv/topics/surveillance/ resources/reports/2009supp_vol14no1/pdf/ HIVAIDS_SSR_Vol14_No1.pdf. Posted June 29, 2009. Accessed July 23, 2009.
4. Hall HI, Song R, Rhodes P, Prejean J, An Q, Lee LM, Karon J, Brookmeyer R, Kaplan EH, McKenna MT, Janssen RS. Estimation of HIV incidence in the United States. JAMA. 2008;300:520-529.
5. Schneider E, Whitmore S, Glynn MK, Dominguez K, Mitsch A, McKenna MT. Revised surveillance case definitions for HIV infection among adults, adolescents, and children aged 18 months and for HIV infection and AIDS among children aged 18 months to 13 years-United States, 2008. MMWR Morbid Mortal Wkly Rep. 2008; 57:1-8.
6. CDC HIV/AIDS Facts: New Estimates of US HIV Prevalence, 2006. Centers for Disease Control and Prevention Web site. http://www.cdc.gov/hiv/topics/surveillance/ resources/factsheets/pdf/prevalence.pdf. Posted October 2008. Accessed July 23, 2009.
7. Anthony MN, Gardner L, Marks G, Anderson-Mahoney P, Metsch LR, Valverde EE, DelRio C, Loughlin AM; Antiretroviral Treatment and Access Study (ARTAS) Study Group. Factors associated with use of HIV primary care among persons recently diagnosed with HIV: Examination of variables from the behavioural model of health-care utilization. AIDS Care. 2007; 19:195-202.
8. Kates J, Levi J. Insurance coverage and access to HIV testing and treatment: Considerations for individuals at risk for infection and for those with undiagnosed infection. Clin Infect Dis. 2007;45(suppl 4): 255-260.
9. Kalichman SC, Pope H, White D, Cherry C, Amaral CM, Swetzes C, Flanagan J, Kalichman MO. Association between health literacy and HIV treatment adherence: Further evidence from objectively measured medication adherence. J Int Assoc Physicians AIDS Care. 2008;7:317-323.
10. Joint United Nations Programme on HIV/ AIDS, World Health Organization, World Food Programme. HIV, food security and nutrition policy brief (expanded version). HIV Policy Web site. http://www.hivpolicy. org/Library/HPP001507.pdf. Accessed July 23, 2009.
11. American Dietetic Association. Position of The American Dietetic Association: Food insecurity and hunger in the United States. J Am Diet Assoc. 2006;106:446-458.
12. American Dietetic Association. Position of The American Dietetic Association: Addressing world hunger, malnutrition, and food insecurity. J Am Diet Assoc. 2003;103:1046-1057.
13. Hughes S, Kelly P. Interactions of malnutrition and immune impairment, with specific reference to immunity against parasites. Parasite Immunol. 2006;18:577-588.
14. Rasouli N, Kern PA. Adipocytokines and the metabolic complications of obesity. J Clin Endocrinol Metab. 2008;93:64-73.
15. Mangili A, Murman DH, Zampini AM, Wanke CA. Nutrition and HIV infection: Review of weight loss and wasting in the era of highly active antiretroviral therapy from the nutrition for healthy living cohort. Clin Infect Dis. 2006;42:836-842.
16. Paton NI, Sangeetha S, Earnest A, Bellamy R. The impact of malnutrition on survival and the CD4 count response in HIV-infected patients starting antiretroviral therapy. HIV Med. 2006;7:323-330.
17. Marazzi MC, Liotta G, Germano P, Guidotti G, Altan AD, Ceffa S, Lio MM, Nielsen-Saines K, Palombi L. Excessive early mortality in the first year of treatment in HIV type 1-infected patients initiating antiretroviral therapy in resource-limited settings. AIDS Res Hum Retroviruses. 2008;24:555-560.
18. Lo J, You SM, Wei J, Canavan B, Grinspoon S. Relationship of peak growth hormone to cardiovascular parameters, waist circumference, lipids and glucose in HIVinfected patients and healthy adults. Clin Endocrinol (Oxf). 2009;71:815-822.
19. Slama L, LeCamus C, Serfaty L, Pialoux G, Capeau J, Gharakhanian S. Metabolic disorders and chronic viral disease: The case of HIV and HCV. Diabetes Metab. 2009;35: 1-11.
20. Llibre JM, Falco V, Tural C, Negredo E, Pineda JA, Muñoz J, Ortega E, Videla S, Sirera G, Martinez E, Miralles C, Iribarren J, Galindo MJ, Domingo P, d'Arminio-Monforte A, Miro JM, Clotet B. The changing face of HIV/AIDS in treated patients. Curr HIV Res. 2009;7:365-377.
21. Faintuch J, Soeters PB, Osmo HG. Nutritional and metabolic abnormalities in pre-AIDS HIV infection. Nutrition. 2006;22: 683-690.
22. Kruzich LA, Marquis GS, Carriquiry AL, Wilson CM, Stephensen CB. US youths in the early stages of HIV disease have low intakes of some micronutrients for optimal immune function. J Am Diet Assoc. 2004; 104:1095-1101.
23. Butensky James E, Harmatz P, Lee M, Kennedy C, Petru A, Wara D, Miaskowski C. Altered iron metabolism in children with human immunodeficiency virus disease. Pediatr Hematol Oncol. 2009;26:69-84.
24. Schaible UE, Kaufmann SHE. Malnutrition and infection: Complex mechanisms and global impacts. PLoS Med. 2007 May; 4:e115.
25. Fergusson P, Chinkhumba J, Grijalva-Eternod C, Banda T, Mkangama C, Tomkins A. Nutritional recovery in HIVinfected and HIV-uninfected children with severe acute malnutrition. Arch Dis Child. 2009;94:512-516.
26. Thomas AM, Mkandawire SC. The impact of nutrition on physiologic changes in persons who have HIV. Nurs Clin North Am. 2006;41:455-468, viii
27. Mocroft A, Ledergerber B, Zilmer K, Kirk O, Hirschel B, Viard JP, Reiss P, Francioli P, Lazzarin A, Machala L, Phillips AN, Lundgren JD; EuroSIDA study group and the Swiss HIV Cohort Study. Short-term clinical disease progression in HIV-1-positive patients taking combination antiretroviral therapy: The EuroSIDA risk-score. AIDS. 2007;21:1867-1875.
28. Srasuebkul P, Lim PL, Lee MP, Kumarasamy N, Zhou J, Sirisanthana T, Li PC, Kamarulzaman A, Oka S, Phanuphak P, Vonthanak S, Merati TP, Chen YM, Sungkanuparph S, Tau G, Zhang F, Lee CK, Ditangco R, Pujari S, Choi JY, Smith J, Law MG. Short-term clinical disease progression in HIV-infected patients receiving combination antiretroviral therapy: Results from the TREAT Asia HIV observational database. Clin Infect Dis. 2009;48: 940-950.
29. Siddiqui J, Phillips AL, Freedland ES, Sklar AR, Darkow T, Harley CR. Prevalence and cost of HIV-associated weight loss in a managed care population. Curr Med Res Opin. 2009;25:1307-1317.
30. Kotler DP, Tierney AR, Wang J, Pierson RN Jr. Magnitude of body-cell-mass depletion and the timing of death from wasting in AIDS. Am J Clin Nutr. 1989;50:444-447.
31. International Dietetic & Nutrition Termonology (IDNT) Reference Manual: Standardized Language for the Nutrition Care Process. 1st ed. Chicago, IL: American Dietetic Association; 2008.
32. Earthman CP. Evaluation of nutritional assessment parameters in the presence of human immunodeficiency virus infection. Nutr Clin Pract. 2004;19:330-339.
33. Centers for Disease Control and Prevention. 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR Morbid Mortal Wkly Rep. 1992;41(RR-17)
34. Siddiqui J, Phillips AL, Freedland ES, Sklar AR, Darkow T, Harley CR. Prevalence and cost of HIV-associated weight loss in a managed care population. Curr Med Res Opin. 2009;25:1307-1317.
35. Campa A, Yang Z, Lai S, Xue L, Phillips JC, Sales S, Page JB, Baum MK. HIV-related wasting in HIV-infected drug users in the era of highly active antiretroviral therapy. Clin Infect Dis. 2005;41:1179-1185.
36. Polsky B, Kotler D, Steinhart C. HIV-associated wasting in the HAART era: Guidelines for assessment, diagnosis, and treatment. AIDS Patient Care STDS. 2001;15: 411-423.
37. Ott M, Lembcke B, Fischer H, Jäger R, Polat H, Geier H, Rech M, Staszeswki S, Helm EB, Caspary WF. Early changes of body composition in human immunodeficiency virus-infected patients: Tetrapolar body impedance analysis indicates significant malnutrition. Am J Clin Nutr. 1993; 57:15-19.
38. Delpierre C, Bonnet E, Marion-Latard F, Aquilina C, Obadia M, Marchou B, Massip P, Perret B, Bernard J. Impact of HIV infection on total body composition in treatment-naive men evaluated by dual-energy x-ray absorptiometry comparison of 90 untreated HIV-infected men to 241 controls. J Clin Densitom. 2007;10:276-380.
39. Galli M, Veglia F, Angarano G, Santambrogio S, Meneghini E, Gritti F, Cargnel A, Mazzotta F, Lazzarin A. Gender differences in antiretroviral drug-related adipose tissue alterations. Women are at higher risk than men and develop particular lipodystrophy patterns. J Acquir Immune Defic Syndr. 2003;34:58-61.
40. Visnegarwala F, Shlay JC, Barry V, Gibert CL, Xiang Y, Wang J, Kotler D, Raghavan S, El-Sadr WM; for Terry Beirn Community Programs for Clinical Research on AIDS (CPCRA). Effects of HIV infection on body composition changes among men of different racial/ethnic origins. HIV Clin Trial. 2007;8:145-154.
41. Demling RH, DeSanti L. The stress response to injury and infection: Role of nutritional support. Medscape Web site. http://www.medscape.com/viewarticle/ 407543.Posted December 1, 2000. Accessed July 31, 2009.
42. Castetbon K, Anglaret X, Touré S, Chêne G, Ouassa T, Attia A, N'Dri-Yoman T, Malvy D, Salamon R, Dabis F; COTRIMO-CI Study Group. Prognostic value of cross-sectional anthropometric indices on short-term risk of mortality in human immunodeficiency virus-infected adults in Abidjan, Côte d'Ivoire. Am J Epidemiol. 2001;154:75-84.
43. Knox TA, Zafonte-Sanders M, Fields-Gardner C, Moen K, Johansen D, Paton N. Assessment of nutritional status, body composition, and human immunodeficiency virus-associated morphologic changes, Clin Infect Dis. 2003;36(suppl 2):63-68.
44. American Dietetic Association. HIV/AIDS Nutrition Evidence Analysis Project. ADA Evidence Analysis Library Web site. http:// www.adaevidencelibrary.com/topic.cfm?cat=1404. Accessed January 26, 2009.
45. Scherzer R, Shen W, Bacchetti P, Kotler D, Lewis CE, Shlipak MG, Heymsfield SB, Grunfeld C; Study of Fat Redistribution Metabolic Change in HIV Infection (FRAM). Simple anthropometric measures correlate with metabolic risk indicators as strongly as magnetic resonance imaging-measured adipose tissue depots in both HIV-infected and control subjects. Am J Clin Nutr. 2008; 87:1809-1817.
46. Guaraldi G, Stentarelli C, Zona S, Orlando G, Carli F, Ligabue G, Lattanzi A, Zaccherini G, Rossi R, Modena MG, Alexopoulos N, Palella F, Raggi P. Lipodystrophy and anti-retroviral therapy as predictors of sub-clinical atherosclerosis in human immunodeficiency virus infected subjects. Atherosclerosis. 2010;208:222-227.
47. Engelson ES, Agin D, Kenya S, Werber-Zion G, Luty B, Albu JB, Kotler DP. Body composition and metabolic effects of a diet and exercise weight loss regimen on obese, HIV-infected women. Metabolism. 2006;55: 1327-1336.
48. Stambullian M, Felieu S, Slobodianik NH. Nutritional status in patients with HIV infection and AIDS. Br J Nutr. 2007;98(suppl 1):140-143.
49. Lichtenstein KA, Delaney KM, Armon C, Ward DJ, Moorman AC, Wood KC, Holmberg SD, HIV Outpatient Study Investigators. Incidence of and risk factors for lipoatrophy (abnormal fat loss) in ambulatory HIV-1-infected patients. J Acquir Immune Defic Syndr. 2003;32:48-56.
50. Nolan D, Hammond E, Martin A, Taylor L, Herrmann S, McKinnon E, Metcalf C, Latham B, Mallal S. Mitochondrial DNA depletion and morphologic changes in adipocytes associated with nucleoside reverse transcriptase inhibitor therapy. AIDS. 2003;17:1329-1338.
51. Gelato MC. Insulin and carbohydrate dysregulation. Clin Infect Dis. 2003;36(suppl 2):91-95.
52. Hepburn MJ, Dyal K, Runser LA, Barfield RL, Hepburn LM, Fraser SL. Low serum vitamin B12 levels in an outpatient HIVinfected population. Int J STD AIDS. 2004; 15:127-133.
53. Jones CY, Tang AM, Forrester JE, Huang J, Hendricks KM, Knox TA, Spiegelman D, Semba RD, Woods MN. Micronutrient levels and HIV disease status in HIV-infeced patients on highly active antiretroviral therapy in the Nutrition for Healthy Living cohort. J Acquir Immune Defic Syndr. 2006;43:475-482.
54. Papathakis PC, Rollins NC, Chantry CJ, Bennish ML, Brown KH. Micronutrient status during lactation in HIV-infected and HIV-uninfected South African women during the first 6 mo after delivery. Am J Clin Nutr. 2007;85:182-192.
55. Drain PK, Baeten JM, Overbaugh J, Wener MH, Bankson DD, Lavreys L, Mandaliya K, Ndinya-Achola JO, McClelland RS. Low serum albumin and the acute phase response predict low serum selenium in HIV-1 infected women. BMC Infect Dis. 2006;6:85.
56. Feldman JG, Goldwasser P, Holman S, De-Hovitz J, Minkoff H. C-reactive protein is an independent predictor of mortality in women with HIV-1 infection. J Acquir Immune Defic Syndr. 2003;32:210-214.
57. Salomon J, de Truchis P, Melchior JC. Body composition and nutritional parameters in HIV and AIDS patients. Clin Chem Lab Med. 2002;40:1329-1333.
58. Rawat R, Stoltzfus RJ, Ntozini R, Mutasa K, Iliff PJ, Humphrey JH. Influence of inflammation as measured by alpha-1-acid glycoprotein on iron status indicators among HIV-positive postpartum Zimbabwean women. Eur J Clin Nutr. 2009;63: 787-793.
59. Mburu AS, Thurnham DI, Mwaniki DL, Muniu EM, Alumasa F, deWagt A. The influence and benefits of controlling for inflammation on plasma ferritin and hemoglobin responses following a multi-micronutrient supplement in apparently healthy, HIV Kenyan adults. J Nutr. 2008;138: 613-619.
60. Eley BS, Sive AA, Shuttleworth M, Hussey GD. A prospective, cross-sectional study of anaemia and peripheral iron status in antiretroviral naive, HIV-1 infected children in Cape Town, South Africa. BMC Infect Dis. 2002;2:3.
61. Northrop-Clewes CA. Interpreting indicators of iron status during an acute phase response-lessons from malaria and human immunodeficiency virus. Ann Clin Biochem. 2008;45:18-32.
62. Moreno A, Bárcena R, García-Gonzalez M, García-Hoz F, Quereda C, Casado JL, Pérez-Elías MJ, Fortún J, Nuño J, Arranz I, Moreno S. Severe sirolimus-related inflammatory state anemia in an HIV liver transplant patient with calcineurin inhibitor renal insufficiency: A case report. Transplant Proc. 2008;40:3810-3812.
63. Buchacz K, Rangel M, Blacher R, Brooks JT. Changes in the clinical epidemiology of HIV infection in the United States: Implications for the clinician. Curr Infect Dis Rep. 2009;11:75-83.
64. Ferrando SJ, Rabkin JG, Lin SH, McElhiney M. Increase in body cell mass and decrease in wasting are associated with increasing potency of antiretroviral therapy for HIV infection. AIDS Patient Care STDS. 2005;19:216-223.
65. Brantley RK, Williams KR, Silva TM, Sistrom M, Thielman NM, Ward H, Lima AA, Guerrant RL. AIDS-associated diarrhea and wasting in Northeast Brazil is associated with subtherapeutic plasma levels of antiretroviral medications with both bovine and human subtypes of Cryptosporidium parvum. Braz J Infect Dis. 2003;7:16-22.
66. Moore RD, Forney D. Anemia in HIV-infected patients receiving highly active antiretroviral therapy. J Acquir Immune Defic Syndr. 2002;29:54-57.
67. López JC, Moreno S, Jiménez-Oñate F, Clotet B, Rubio R, Hernández-Quero J. A cohort study of the food effect on virological failure and treatment discontinuation in patients on HAART containing didanosine enteric-coated capsules (FOODDIe Study). HIV Clin Trials. 2006;7:155-162.
68. Spada C, Treitinger A, Reis M, Masokawa IY, Verdi JC, Luiz MC, Silveira MV, Oliveira OV, Michelon CM, Avial-Junior S, Gil DO, Ostrowsky S. An evaluation of antiretroviral therapy associated with alphatocopherol supplementation in HIV-infected patients. Clin Chem Lab Med. 2002;40:456-459.
69. Positively Aware: 13th Annual HIV drug guide. March/April 2009. Test Positive Aware Network Web site. http://positivelyaware.com/ 2009/09_02/09_02.pdf. Posted March 2009. Accessed April 21, 2009.
70. Fichtenbaum CJ. Metabolic abnormalities associated with HIV infection and antiretroviral therapy. Curr Infect Dis Rep. 2009; 11:84-92.
71. Rotger M, Csajka C, Telenti A. Genetic, ethnic, and gender differences in the pharmacokinetics of antiretroviral agents. Curr HIV/AIDS Reports. 2006;3:118-125.
72. Nicastri E, Leone S, Angeletti C, Palmisano L, Sarmati L, Chiesi A, Geraci A, Vella S, Narciso P, Corpolongo A, Andreoni M. Sex issues in HIV-1-infected persons during highly active antiretroviral therapy: A systematic review. J Antimicrob Chemother. 2007;14:407-410.
73. Vining L. General nutrition issues for healthy living with HIV infection. In: Hendricks KM, Dong KR, Gerrior J, eds. Nutrition Management of HIV and AIDS. Chicago, IL: American Dietetic Association; 2009:23-29.
74. Kupka R, Mugusi F, Aboud S, Msamanga GI, Finkelstein JL, Spiegelman D, Fawzi WW. Randomized, double-blind, placebocontrolled trial of selenium supplements among HIV-infected pregnant women in Tanzania: Effects on maternal and child outcomes. Am J Clin Nutr. 2008;87:1802-1808
75. Baylin A, Villamor E, Rifai N, Msamanga G, Fawzi WW. Effect of vitamin supplementation to HIV-infected pregnant women on the micronutrient status of their infants. Eur J Clin Nutr. 2005;59:960-968.
76. Fawzi WW, Msamanga GI, Spiegelman D, Wei R, Kapiga S, Villamor E, Mwakagile D, Mugusi F, Hertzmark E, Essex M, Hunter DJ. A randomized trial of multivitamin supplements and HIV disease progression and mortality.NEngl J Med. 2004;351:23-32.
77. Baum MK, Campa A, Lai S, Lai H, Page JB. Zinc status in human immunodeficiency virus type 1 infection and illicit drug use. Clin Infect Dis. 2003;37(suppl 2):117-123.
78. Majaliwa ES, Mohn A, Chiarelli F. Growth and puberty in children with HIV infection. J Endocrinol Invest. 2009;32:85-90.
79. Dabis F, Newell ML, Fowler MG, Read JS. Ghent IAS Working Group on HIV in Women and Children. Prevention of HIV transmission through breast-feeding: Strengthening the research agenda. J Acquir Immune Defic Syndr. 2004;35:167-168.
80. Thomas AM, Mkandawire SC. The impact of nutrition on physiologic changes in persons who have HIV. Nurs Clin North Am. 2006;41:455-468, viii.
81. Friedland GH. HIV medication adherence. The intersection of biomedical, behavioral, and social science research and clinical practice. J Acquir Immune Defic Syndr. 2006;43(suppl 1):3-9.
82. Kitahata MM, Van Rompaey SE, Dillingham PW, Koepsell TD, Deyo RA, Dodge W, Wagner EH. Primary care delivery is associated with greater physician experience and improved survival among persons with AIDS. J Gen Intern Med. 2003;18:95-103.
83. Siddiqui U, Bini EJ, Chandarana K, Leong J, Ramsetty S, Schiliro D, Poles M. Prevalence and impact of diarrhea on healthrelated quality of life in HIV-infected patients in the era of highly active antiretroviral therapy. J Clin Gastroenterol. 2007;41:484-490.
84. Kremer H, Sonnenberg-Schwan U, Arendt G, Brockmeyer NH, Potthoff A, Ulmer A, Graefe K, Lorenzen T, Starke W, Walker UA; German Competence Network HIV/AIDS. HIV or HIV-therapy? Causal attributions of symptoms and their impact on treatment decisions among women and men with HIV. Eur J Med Res. 2009;14:139-146.
85. Okoror TA, Airhihenbuwa CO, Zungu M, Makofani D, Brown DC, Iwelunmor J. "My mother told me I must not cook anymore"- Food, culture, and the context of HIV-and AIDS-related stigma in three communities in South Africa. Int Q Community Health Educ. 2007-2008;28:201-213.
86. Diet and Disease. HIV/AIDS. US Department of Agriculture Web site. http://fnic.nal.usda. gov/nal_display/index.php=info_center=4&tax_level=-2&tax_subject±278&topic_id=1380. Accessed July 16, 2009.
87. Zotor FB, Amuna P. The food multimix concept: New innovative approach to meeting nutritional challenges in sub-Saharan Africa. Proc Nutr Soc. 2008;67:98-104.
88. Reid C, Courtney M. A randomized clinical trial to evaluate the effect of diet on weight loss and coping of people living with HIV and lipodystrophy. J Clin Nurs. 2007;16: 197-206.
89. Crenn P, Rakotoanbinina B, Raynaoud JJ, Thuillier F, Messign B, Melchior JC. Hyperphagia contributes to the normal body composition and protein-energy balance in HIV-infected asymptomatic men. J Nutr. 2004;134:2301-2306.
90. Batterham MJ. Investigating heterogeneity in studies of resting energy expenditure in persons with HIV/AIDS: A meta-analysis. Am J Clin Nutr. 2005;81:702-713.
91. Fitch KV, Guggina LM, Keough HM, Donal Looby SE, Hadigan C, Anderson EJ, Hubbard J, Liebau JG, Johnsen S, Wei J, Makimura H, Stanley TL, Lo J, Grinspoon SK. Decreased respiratory quotient in relation to resting energy expenditure in HIVinfected and noninfected subjects. Metabolism. 2009;58:608-615.
92. Kosmiski LA, Bessesen DH, Stotz SA, Koeppe JR, Horton TJ. Short-term energy restriction reduces reseting energy expenditure in patients with HIV lipodystrophy and hypermetabolism. Metabolism. 2007; 56:289-295.
93. Kulstad R, Schoeller DA. The energetics of wasting diseases. Curr Opin Clin Nutr Metab Care. 2007;10:488-493.
94. Mwamburi DM, Wilson IB, Jacobson DL, Spiegelman D, Gorbach SL, Knox TA, Wanke CA. Understanding the role of HIV load in determining weight change in the era of highly active antiretroviral therapy. Clin Infect Dis. 2005;40:167-173.
95. Campa A, Yang Z, Lai S, Xue L, Phillips JC, Sales S, Page JB, Baum MK. HIV-related wasting in HIV-infected drug users in the era of highly active antiretroviral therapy. Clin Infect Dis. 2005;41:1179-1185.
96. Williams S.B., Bartsch G., Muurahainen N., Collins G., Raghavan S.S, Wheeler D. Protein intake is positively associated with body cell mass in weight stable HIV infected men. J Nutr. 2003;133:1143-1146.
97. Katona P, Katona-Apte J. The interaction between nutrition and infection. Clin Infect Dis. 2008;46:1582-1588.
98. Amati L, Cirimele D, Pugliese V, Covelli V, Resta F, Jirillo E. Nutrition and immunity: Laboratory and clinical aspects. Curr Pharm Des. 2003;9:1924-1931.
99. Hendricks KM, Dong KR, Tang AM, Ding B, Spiegelman D, Woods MN, Wanke CA. High-fiber diet in HIV-positive men is associated with lower risk of developing fat deposition. Am J Clin Nutr. 2003;78:790-795.
100. Shah M, Tierney K, Adams-Huet B, Boonyavarakul A, Jacob K, Quittner C, Dinges W, Peterson D, Garg A. The role of diet, exercise and smoking in dyslipidaemia in HIV-infected patients with lipodystrophy. HIV Med. 2005;6:291-298.
101. Tsiodras S, Poulia KA, Yannakoulia M, Chimienti SN, Wadhwa S, Karchmer AW, Mantzoros CS. Adherence to Mediterranean diet is favorably associated with metabolic parameters in HIV-positive patients with the highly active antiretroviral therapy-induced metabolic syndrome and lipodystrophy. Metabolism. 2009;58:854-859.
102. Samaras K, Wand H, Law M, Emery S, Cooper DA, Carr A. Dietary intake in HIVinfected men with lipodystrophy: Relationships with body composition, visceral fat, lipid, glucose and adipokine metabolism. Curr HIV Res. 2009;7:454-461.
103. Wohl DA, Tien HC, Busby M, Cunningham C, Macintosh B, Napravnik S, Danan E, Donovan K, Hossenipour M, Simpson RJ Jr. Randomized study of the safety and efficacy of fish oil (omega-3 fatty acid) supplementation with dietary and exercise counseling for the treatment of antiretroviral therapy-associated hypertriglyceridemia. Clin Infect Dis. 2005;41:1498-1504.
104. Oosthuizen W, van Graan A, Kruger A, Vorster HH. Polyunsaturated fatty acid intake is adversely related to liver function in HIV-infected subjects: The THUSA study. Am J Clin Nutr. 2006;83:1193-1198.
105. Fawzi WW, Msamanga GI, Wei R, Spiegelman D, Antelman G, Villamor E, Manji K, Hunter D. Effect of providing vitamin supplements to human immunodeficiency virus-infected lactating mothers on the child's morbidity and CD4 cell counts. Clin Infect Dis. 2003;36:1053-1062.
106. Baum MK, Campa A, Lai S, Lai H, Page JB. Zinc status in human immunodeficiency virus type 1 infection and illicit drug use. Clin Infect Dis. 2003;37(suppl 2):117-123.
107. Baum MK, Miguez-Burbano MJ, Campa A, Shor-Posner G. Selenium and interleukins in persons infected with human immunodeficiency virus type 1. J Infect Dis. 2000; 182(suppl 1):69-73.
108. Woods MN, Spiegleman D, Knox TA, Forrester JE, Connors JL, Skinner SC, Silva M, Kim JH, Gorbach SL. Nutrient intake and body weight in a large HIV cohort that includes women and minorities. J Am Diet Assoc. 2002;102:203-211.
109. Bhasin S, Parker RA, Sattler F, Haubrich R, Alston B, Umbleja T, Shikuma CM; AIDS Clinical Trials Group Protocol A5079 Study Team. Effects of testosterone supplementation on the whole body and regional fat mass and distribution in human immunodeficiency virus-infected men with abdominal obesity. J Clin Endocrinol Metab. 2007;92:1049-1057.
110. Lynch GS, Schertzer JD, Ryall JG. Therapeutic approaches for muscle wasting disorders. Pharmacol Ther. 2007;113:461-487.
111. Lo J, You SM, Canavan B, Liebau J, Beltrani G, Koutkia P, Hemphill L, Lee H, Grinspoon S. Low-dose physiological growth hormone in patients with HIV and abdominal fat accumulation: A randomized controlled trial. JAMA. 2008;300:509-519.
112. He Q, Engelson ES, Kotler DP. A comparison of abdominal subcutaneous adipose tissue pattern in obese and lean HIV-infected women. Nutr. 2005;135:53-57.
113. Leyes P, Martinez E, Forga Mde T. Use of diet, nutritional supplements and exercise in HIV-infected patients receiving combination antiretroviral therapies: A systematic review. Antivir Ther. 2008;13:149-159.
114. Mulligan K, Khatami H, Schwarz JM, Sakkas GK, DePaoli AM, Tai VW, Wen MJ, Lee GA, Grunfeld C, Schambelan M. The effects of recombinant human leptin on visceral fat, dyslipidemia, and insulin resistance in patients with human immunodeficiency virus-associated lipoatrophy and hypoleptinemia. J Clin Endocrinol. 2009;94:1137-1144.
115. Macallan DC, Baldwin C, Mandalia S, Pandol-Kaljevic V, Higgins N, Grundy A, Moyle GJ. Treatment of altered body composition in HIV-associated lipodystrophy: Comparison of rosiglitazone, pravastatin, and recombinant human growth hormone. HIV Clin Trials. 2008;9:254-268.
116. Polo R, Gómez-Candela C, Miralles C, Locutura J, Alvarez J, Barreiro F, Bellido D, Câncer E, Cánoves D, Domingo P, Estrada V, Fumaz CR, Galindo MJ, García-Benayas T, Iglesias C, Irles JA, Jiménez-Nacher I, Lozano F, Marqués I, Martínez-Alvarez JR, Mellado MJ, Miján A, Ramos JT, Riobo P; SPNS/GEAM/SENBA/SENPE/ AEDN/SEDCA/ GESIDA. Recommendations from SPNS/GEAM/SENBA/SENPE/ AEDN/SEDCA/GESIDA on nutrition in the HIV-infected patient. Nutr Hosp. 2007;22: 229-243.
117. Dolan SE, Frontera W, Librizzi J, Ljungquist K, Juan S, Dorman R, Cole ME, Kanter JR, Grinspoon S. Arch Intern Med. 2006;166:1225-1231.
118. Lindegaard B, Hansen T, Hvid T, van Hall G, Plomgaard P, Ditlevsen S, Gersstoft J, Pedersen BK. The effect of strength and endurance training on insulin sensitivity and fat distribution in human immunodeficiency virus-infected patients with lipodystrophy. J Clin Endocrinol Metab. 2008; 93;3860-3869.
119. Lundgren JD, Battegay M, Behrens G, De Wit S, Guaraldi G, Katlama C, Martinez E, Nair D, Powderly WG, Reiss P, Sutinen J, Vigano A; EACS Executive Committee. European AIDS Clinical Society (EACS) guidelines on the prevention and management of metabolic diseases in HIV. HIV Med. 2008;9:72-81.
120. Lagathu C, Kim M, Maachi M, Vigouroux C, Cervera P, Capeau J, Caron M, Bastard JP. HIV antiretroviral treatment alters adipokine expression and insulin sensitivity of adipose tissue in vitro and in vivo. Biochimie. 2005;87: 65-71.
121. Diehl LA, Fabris BA, Barbosa DS, De Faria EC, Wiechmann SL, Carrilho AJ. Metformin increases HDL3-cholesterol and decreases subcutaneous truncal fat in nondiabetic patients with HIV-associated lipodystrophy. AIDS Patient Care STDS. 2008;22:779-786.
122. Schindler K, Rieger A, Tura A, Gmeinhardt B, Touzeau-Römer V, Haider D, Pacini G, Ludvik B. The effect of rosiglitazone on insulin sensitivity, beta cell function, bone mineral density, and body composition in HIV-positive patients on highly-active antiretroviral therapy (HAART). Horm Metab Res. 2009;41:573-579.
123. Mulligan K, Yang Y, Wininger DA, Koletar SL, Parker RA, Alston-Smith BL, Schouten JT, Fielding RA, Basar MT, Grinspoon S. Effects of metformin and rosiglitazone in HIV-infected patients with hyperinsulinemia and elevated waist/hip ratio. AIDS. 2007;21:47-57.
124. Mondy K, Tebas P. Emerging bone problems in patients infected with human immunodeficiency virus. Clin Infect Dis. 2003; 36(suppl 2):101-105.
125. Rapid advice: RevisedWHOprinciples and recommendations on infant feeding in the context of HIV-November 2009. World Health Organization Web site. http://whqlibdoc.who.int/ publications/2009/9789241598873_eng.pdf. Posted November 2009. Accessed January 18, 2010.
126. Expert consultation on new and emergency evidence on the use of ARV drugs for the prevention of MCTC of HIV. World Health Organization Web site. http://www.who.int/hiv/topics/ mtct/mtct_conclusions_consult.pdf. Posted December 15, 2008. Accessed July 24, 2009.
127. Becquet R, Bequet L, Ekouevi DK, Viho I, Sakarovitch C, Fassinou P, Bedikou G, Timite-Konan M, Dabis F, Leroy V; ANRS 1201/1202 Ditrame Plus Study Group. Two-year morbidity-mortality and alternatives to prolonged breast-feeding among children born to HIV-infected mothers in Cote d-Ivoire. PLoS Med. 2007;4:e17.
128. Kumwenda NI, Hoover DR, Mofenson LM, Thigpen MC, Kafulafula G, Li Q, Mipando L, Nkanaunena K, Mebrahtu T, Bulterys M, Fowler MG, Taha TE. Extended antiretroviral prophylaxis to reduce breast-milk HIV-1 transmission. N Engl J Med. 2008; 359:119-129.
129. Kuhn L, Aldrovandi GM, Sinkala M, Kankasa C, Semrau K, Mwiya M, Kasonde P, Scott N, Vwalika C, Walter J, Bulterys M, Tsai WY, Thea DM; Zambia Exclusive Breastfeeding Study. Effects of early, abrupt weaning on HIV-free survival of children in Zambia. N Engl J Med. 2008; 359:130-141.
130. Tournoud M, Ecochard R, Kuhn L, Coutsoudis A. Diversity of risk of mother-to-child HIV-1 transmission according to feeding practices, CD4cell count, and haemoglobin concentration in a South African cohort. TropMedInt Health. 2008;13:310-318.
131. Johann-Liang R, O'Neill L, Cervia J, Haller I, Giunta Y, Licholai T, Noel GJ. Energy balance, viral burden, insulin-like growth factor-1, interleukin-6 and growth impairment in children infected with human immunodeficiency virus. AIDS. 2000;14:683-690.
132. Chhagan MK, Van den Broeck J, Luabeya KK, Mpontshane N, Tucker KL, Bennish ML. Effect of micronutrient supplementation on diarrhoeal disease among stunted children in rural South Africa. Eur J Clin Nutr. 2009;63:850-857.
133. Allen LH, Peerson JM, Olney DK. Provision of multiple rather than two or fewer micronutrients more effectively improves growth and other outcomes in micronutrient-deficiency children and adults. J Nutr. 2009;139: 1022-1030.
134. Duvivier C, Kolta S, Assoumou L, Ghosn J, Rozenberg S, Murphy RL, Katlama C, Costagliola D; ANRS 121 Hippocampe study group. Greater decrease in bone mineral density with protease inhibitor regimens compared with nonnucleoside reverse transcriptase inhibitor regimens in HIV-infected naïve patients. AIDS. 2009; 27:817-824.
135. Boesecke C, Cooper DA. Toxicity of HIV protease inhibitors: Clinical considerations. Curr Opin HIV AIDS. 2008;3:653-659.
136. Chubineh S, McGowan J. Nausea and vomiting in HIV: A symptom review. Int J STD AIDS. 2008;19:723-728.
137. Nwachukwu CE, Okebe JU. Antimotility agents for chronic diarrhoea in people with HIV/AIDS. Cochrane Database Syst Rev. 2008;4:CD005644.
138. Willard S, Holzemer WL, Wantland DJ, Cuca YP, Kirksey KM, Portillo CJ, Corless IB, Rivero-Méndez M, Rosa ME, Nicholas PK, Hamilton MJ, Sefcik E, Kemppainen J, Canaval G, Robinson L, Moezzi S, Human S, Arudo J, Sanzero Eller L, Bunch E, Dole PJ, Coleman C, Nokes K, Reynolds NR, Tsai YF, Maryland M, Voss J, Lindgren T. Does "asymptomatic" mean without symptoms for those living with HIV infection? AIDS Care. 2009;21:322-328.
139. Hengge UR, Stocks K, Wiehler H, Faulkner S, Esser S, Lorenz C, Jentzen W, Hengge D, Goos M, Dudley RE, Ringham G. Double-blind, randomized, placebo-controlled phase III trial of oxymetholone for the treatment of HIV wasting. AIDS. 2003;17: 699-710.
140. Cofrancesco J Jr, Freedland E, McComsey G. Treatment options for HIV-associated central fat accumulation. AIDS Patient Care STDS. 2009;23:5-18.
141. Johnson L, Jarvis JN, Wilkins EG, Hay PE. Thalidomide treatment for refractory HIVassociated colitis: A case series. Clin Infect Dis. 2008;47:133-136.
142. Shetty K. Current role of thalidomide in HIV-positive patients with recurrent aphthous ulcerations. Gen Dent. 2007;55:537-542.
143. Matthews SJ, McCoy C. Thalidomide A review of approved and investigational uses. Clin Ther. 2003;25:342-395.
144. Littlewood RA, Vanable PA. Complementary and alternative medicine use among HIV-positive people: Research synthesis and implications for HIV care. AIDS Care. 2008;20:1002-1018.
145. Liu JP, Manheimer E, Yang M. Herbal medicines for treating HIV infection and AIDS. Cochrane Database Syst Rev. 2005; 20:CD003937.
146. Landenheim D, Horn O, Werneke U, Phillpot M, Murungi A, Theobald N, Orkin C. Potential health risks of complementary alternative medicines in HIV patients. HIV Med. 2008;9:653-659.
147. Dietitians of Canada. Hepatitis C Nutrition Care Guidelines Course. Dietetics Work Web site. http://www.dieteticsatwork.com/hepC_ moreinfo.asp. Posted March 2003. Accessed July 24, 2009.
148. Hepatitis C. US Department of Veterans Affairs Web site. http://www.hepatitis.va. gov/vahep?page=diet-00-00. Posted February 7, 2007. Accessed July 24, 2009.
149. Pub L No. 109-415. Ryan White HIV/AIDS Treatment Modernization Act of 2006.
150. Lo W, MacGovern T, Bradford J. Association of ancillary services with primary care utilization and retention for patients with HIV/AIDS. AIDS Care. 2002;14(suppl 1): 45-57.
151. Institute of Medicine. Care without Coverage, Too Little, Too Late. Washington, DC: National Academies Press; 2002.
152. Fenton M, Silverman E, Vazzo L. HIV/ AIDS adult medical nutrition therapy protocol. In: Gilbreath J, Inman-Felton A, Johnson EQ, Robinson G, Smith K, eds. Medical Nutrition Therapy Across the Continuum of Care. Chicago, IL: American Dietetic Association; 1998.
153. Heller L, Rothpletz-Puglia P, Morris V, Papathakis P. HIV/AIDS children/adolescents medical nutrition therapy protocol. In: Gilbreath J, Inman-Felton A, Johnson EQ, Robinson G, Smith K, eds. Medical Nutrition Therapy Across the Continuum of Care. Chicago, IL: American Dietetic Association; 1998.